Immunocompromised Archives - Page 2 of 2

AstraZeneca’s antibody therapy prevents COVID-19, study shows

AstraZeneca, Clinical Data, Clinical Trials, COVID-19 Antibodies, COVID-19 Vaccinations, Covid-19 Variants, Delta Variant (B.1.617.2; India), Immune System, Immunocompromised, Monoclonal Antibodies, R&D, SARS-CoV-2 virus, Vanderbilt University

Trial data from AstraZeneca on Aug. 20 raised the prospect of a new treatment to prevent Covid-19 beyond vaccines, giving hope in particular for people who respond poorly to immunization shots.

August 20, 2021/by Reuters Health

U.S. FDA authorizes COVID-19 vaccine boosters for the immunocompromised

BioNTech, BNT162b2 (Pfizer and BioNTech), Business, COVID-19 booster shots, COVID-19 Studies, COVID-19 Vaccines, Delta Variant (B.1.617.2; India), Emergency Use Authorization (EUA), FDA, Germany, Immune System, Immunocompromised, Israel, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pfizer, Scientists, Shares

The U.S. Food and Drug Administration authorized a third dose of Covid-19 vaccines by Pfizer-BioNTech and Moderna for people with compromised immune systems.

August 13, 2021/by Reuters Health